🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

6+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 6 recruiting trials for “thyroid-hypoplasia”

Phase 2Enrolling by InvitationNCT07393373 ↗

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

👨‍⚕️ QED Therapeutics SVP, Clinical Development, QED Therapeutics, a BridgeBio company📍 25 sites📅 Started Apr 2026View details ↗
Phase 2RecruitingNCT07126262 ↗

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

🏥 BioMarin Pharmaceutical📍 26 sites📅 Started Jul 2025View details ↗
Phase 3Enrolling by InvitationNCT07073014 ↗

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

🏥 BioMarin Pharmaceutical📍 23 sites📅 Started Jun 2025View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT06873035 ↗

An Interventional Study of Infigratinib in Children With Hypochondroplasia

🏥 QED Therapeutics, a BridgeBio company📍 22 sites📅 Started Apr 2025View details ↗
RecruitingNCT06410976 ↗

Prospective Clinical Assessment Study in Children With Hypochondroplasia

🏥 QED Therapeutics, a BridgeBio company📍 25 sites📅 Started Jun 2024View details ↗
RecruitingNCT06212947 ↗

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

👨‍⚕️ Medical Director, MD, BioMarin Pharmaceutical📍 43 sites📅 Started Nov 2023View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →